Neumora Therapeutics, Inc. (NMRA) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
8/25
Growth 2
Margin 1
Expansion 3
Platform 0
Financial 2
latest quarter score
Earnings Reports
- 8
- 9
- 9